For EC, a recent study demonstrated that ESCC cells escape ferroptosis caused by elevated lipid peroxidation by upregulating GPX4 and SLC7A11, indicating that targeting GPX4 to block this intrinsic protective mechanism against ferroptosis has great potential for the treatment of EC 200. Here, GPX4 is linked to esophageal squamous cell carcinoma.